Nektar Therapeutics (NKTR)
68.42
-5.20
(-7.06%)
USD |
NASDAQ |
Feb 24, 16:00
67.96
-0.46
(-0.67%)
After-Hours: 07:53
Nektar Therapeutics Shareholders Equity (Annual) : 60.74M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Rigel Pharmaceuticals, Inc. | 3.288M |
| Insmed, Inc. | 738.98M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Ironwood Pharmaceuticals, Inc. | -301.34M |
| Lyell Immunopharma, Inc. | 382.82M |